Pre-targeting of polymeric nanomaterials to balance tumour accumulation and clearance†
Abstract
Pre-targeting of bispecific antibodies is probed to enhance tumour retention while limiting clearance of administered multifunctional branched PEGylated nanomedicines. The temporal influence of pre-targeting on polymer interaction with tumour cells and tissue is explored using in vitro assays through to preclinical validation.
- This article is part of the themed collections: Celebrating 10 years of ChemComm Emerging Investigators and Chemical Communications HOT Articles 2022